0001564590-19-006771 Sample Contracts

Amended and Restated Patent License Agreement Agreement No. PM1401501

Patent License Agreement • March 7th, 2019 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas

• Contract Type
  Patent License Agreement
• Filed
  March 7th, 2019
• Company
  Aeglea BioTherapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Texas

This Amended and Restated Patent License Agreement (“Patent License Agreement”) is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).

AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

Investor Rights Agreement • March 7th, 2019 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Investor Rights Agreement
• Filed
  March 7th, 2019
• Company
  Aeglea BioTherapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Amendment No. 1 to Amended and Restated Investor Rights Agreement (this “Amendment”) is entered into as of December 4, 2018 by the undersigned parties to that certain Amended and Restated Investor Rights Agreement, dated as of March 10, 2015 (the “Rights Agreement”), by and among Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”) and the Investors. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Rights Agreement.